Webinar: Ataluren and the Current Regulatory Landscape
by: Parent Project Muscular Dystrophy
In this webinar, PPMD’s Pat Furlong is joined by Barrett Tenbarge from Faegre Drinker and Matt Klein from PTC Therapeutics to discuss the current regulatory landscape and the FDA’s framework for therapies that are not FDA-approved.